Recovery
BPC-157
Injection
Recovery & performance
Low-Dose Naltrexone
Explore off-label low-dose naltrexone, evidence limitations, and opioid-related precautions.
Medical guidance
Clinical review required
3
Prices are indicative market-aligned medication pricing, not a quote. A licensed pharmacy confirms the final price for the exact formulation after a state-licensed clinician reviews your case.
No published telehealth price was found for this compound.
Availability and treatment are not guaranteed.
vidameds
Compounded medications are not FDA-approved.
Understanding Low-Dose Naltrexone
Know the treatment.
Ask better questions.
Low-Dose Naltrexone, often called LDN, describes off-label use of naltrexone at lower doses than approved addiction-treatment regimens. The pictured label does not specify dose or delivery form. This listing does not establish benefits for any individual condition.
How it works
Naltrexone blocks opioid receptors. Proposed additional effects of low-dose use remain under investigation, and a proposed mechanism does not prove benefit for chronic pain or inflammatory conditions.
Safety & suitability
Naltrexone can block opioid pain medicines and precipitate withdrawal in someone using opioids. A clinician must review current medicines, opioid exposure, liver health, and other risks. Do not start, stop, or change medicines based on this page.
Bring to your care conversation
- What evidence supports use for my diagnosis, and how does it interact with opioid medicines?
- What is the exact formulation, and which approved alternatives should I consider?
- What side effects, interactions, and follow-up should we discuss before a decision?
Research, in perspective
What the evidence says.
Condition-specific research. Mixed findings.
A 2024 randomized trial in 99 women with fibromyalgia tested oral low-dose naltrexone against placebo for 12 weeks. It did not demonstrate superior pain reduction.
That finding does not settle every dose or condition, but it does not support a broad pain-relief promise. Standard-dose approval for addiction-related indications does not establish approval of low-dose compounded formulations.
Read the sourcesEvidence at a glance
What has been studied
Small condition-specific studies, including a negative fibromyalgia trial.
What remains unknown
Consistent benefit across proposed pain and inflammatory conditions.
What this means for you
Evidence must match the ingredient, formulation, and condition. A biological mechanism is not a guaranteed clinical result.
01
Opioid receptor blockade
02
Other proposed effects remain under study
03
Clinical benefit must be assessed condition by condition
Sources & further reading
- 01Naltrexone for fibromyalgia: Randomized placebo-controlled trial (2024)
- 02DailyMed: Naltrexone hydrochloride tablets prescribing information
Research context is educational and does not confirm the safety, effectiveness, or availability of the pictured product.
The Vida Meds difference
Connected care.
Personal at every step.
A nationwide provider network. Direct pharmacy pricing. A team you can reach.
200+
Licensed providers
A nationwide network of licensed clinicians.
50 states
Nationwide care
Our provider network spans all 50 states.
Direct pharmacy
Pricing
Direct Pharmacy Pricing for your treatment.
Overnight
ColdChain Shipping
Temperature-controlled shipping for medications that require it.
24-hour
Customer support
Support for your questions, around the clock.
Direct access
Patient portal
Connect with your provider and dedicated care team.
Treatment eligibility, medication availability, and shipping arrangements depend on clinical review and the prescribed medication. Customer support is not emergency care; call 911 for a medical emergency.
Beyond the medication
Make room for recovery.
Recovery is part of progress. Explore the role of rest, rehabilitation, and medical evaluation—and take a clear-eyed look at emerging peptide research.
Explore recovery & performance
